Potential new drug to treat severe, uncontrolled asthma

person getting a vaccination shot
Trial results suggest treatment could be used as an add-on therapy for severely asthmatic patientsTwo phase III, double-blind, randomised controlled trials including more than 2500 participants looked at the safety and efficacy of benralizumab injections as an add-on therapy for patients with severe, uncontrolled asthma.Benralizumab targets the IL-5 receptor that drives the proliferation of eosinophils –

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Rivaroxaban resource now available
Next Medicines: the state of the nation